The Quest for Histology Driven Neoadjuvant Chemotherapy in Soft-Tissue Sarcoma: End of Road or Just the Beginning?

CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2018; 39(04): 427-428
DOI: 10.4103/ijmpo.ijmpo_248_17

Editorial Commentary

Aditi Aggarwal

Department of Radiation Oncology, Lok Nayak Hospital and Maulana Azad Medical College, New Delhi, India

,

Atul Sharma

Department of Medical Oncology, IRCHH, AIIMS, New Delhi, India

,

Sameer Rastogi

Department of Medical Oncology, IRCHH, AIIMS, New Delhi, India

References
1 Press Announcements – FDA Approves First Drug to Show Survival Benefit in Liposarcoma. Available from: https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm483714.htm. [Last accessed on 2017 Sep 20].
2 Press Announcements – FDA Approves New Therapy for Certain Types of Advanced Soft Tissue Sarcoma. Available from: https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm468832.htm. [Last accessed on 2017 Sep 20].
3 Gronchi A, Ferrari S, Quagliuolo V, Broto JM, Pousa AL, Grignani G. et al. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): An international, open-label, randomised, controlled, phase 3, multicentre trial. Lancet Oncol 2017; 18: 812-22
4 Gronchi A, Bui BN, Bonvalot S, Pilotti S, Ferrari S, Hohenberger P. et al. Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma. Ann Oncol 2012; 23: 771-6
5 Ducoulombier A, Cousin S, Kotecki N, Penel N. Gemcitabine-based chemotherapy in sarcomas: A systematic review of published trials. Crit Rev Oncol Hematol 2016; 98: 73-80
6 Gronchi A, Frustaci S, Mercuri M, Martin J, Lopez-Pousa A, Verderio P. et al. Short, full-dose adjuvant chemotherapy in high-risk adult soft tissue sarcomas: A randomized clinical trial from the Italian sarcoma group and the Spanish sarcoma group. J Clin Oncol 2012; 30: 850-6